FCGR3A and diffuse large B-cell lymphoma: Moreover, the results showed that percentageof the CD16+ NK cells from responsive DLBCL patients wasmore than refractory/relapsed DLBCL patients in the absenceof exosomes or presence of IL-2/IL-15 (P=0.0001 and P=0.002,respectively).